Intra-Cellular Therapies Inc
NASDAQ:ITCI

Watchlist Manager
Intra-Cellular Therapies Inc Logo
Intra-Cellular Therapies Inc
NASDAQ:ITCI
Watchlist
Price: 131.87 USD -0.04% Market Closed
Market Cap: 14B USD

Wall Street
Price Targets

ITCI Price Targets Summary
Intra-Cellular Therapies Inc

There are no price targets for ITCI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Intra-Cellular Therapies Inc Competitors:
Price Targets
CLN
Celon Pharma SA
24% Upside
MRK
Merck KGaA
50% Upside
DRREDDY
Dr Reddy's Laboratories Ltd
11% Upside
002294
Shenzhen Salubris Pharmaceuticals Co Ltd
10% Upside
VRNA
Verona Pharma PLC
27% Upside
600572
Zhejiang CONBA Pharmaceutical Co Ltd
68% Upside

Revenue
Forecast

Revenue Estimate
Intra-Cellular Therapies Inc

For the last 8 years the compound annual growth rate for Intra-Cellular Therapies Inc's revenue is 163%. The projected CAGR for the next 3 years is 48%.

163%
Past Growth
48%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Intra-Cellular Therapies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Intra-Cellular Therapies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ITCI's stock price target?
Not Available

ITCI doesn't have any price targets made by Wall Street professionals.

What is Intra-Cellular Therapies Inc's Revenue forecast?
Projected CAGR
48%

For the last 8 years the compound annual growth rate for Intra-Cellular Therapies Inc's revenue is 163%. The projected CAGR for the next 3 years is 48%.

Back to Top